Attached files
file | filename |
---|---|
EX-32.01 - EXHIBIT 32.01 - BioSig Technologies, Inc. | ex_233029.htm |
EX-31.02 - EXHIBIT 31.02 - BioSig Technologies, Inc. | ex_233028.htm |
EX-31.01 - EXHIBIT 31.01 - BioSig Technologies, Inc. | ex_233027.htm |
EX-23.1 - EXHIBIT 23.1 - BioSig Technologies, Inc. | ex_233376.htm |
EX-21.1 - EXHIBIT 21.1 - BioSig Technologies, Inc. | ex_233026.htm |
EX-4.1 - EXHIBIT 4.1 - BioSig Technologies, Inc. | ex_233025.htm |
10-K - FORM 10-K - BioSig Technologies, Inc. | biosig20201231_10k.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File Nos. 333-251859, 333-230448, 333-231862, 333-204335, 333-218583 and 333-223298) and Form S-8 (File No. 333-208807) of our report dated March 15, 2021, relating to the consolidated financial statements BioSig Technologies, Inc. for the year ended December 31, 2020, which appear in this Form 10-K.
/s/ Friedman LLP
Marlton, New Jersey
March 15, 2021